{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:58:46Z","timestamp":1782359926107,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ridd.2013.08.015","type":"journal-article","created":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T21:45:14Z","timestamp":1382910314000},"page":"4293-4303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: A systematic review"],"prefix":"10.1016","volume":"34","author":[{"given":"Frances","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Tharian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoumitro","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma L.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ridd.2013.08.015_bib0005","first-page":"485","article-title":"The aberrant behaviour check list: A behaviour rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"key":"10.1016\/j.ridd.2013.08.015_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0149-7634(05)80036-3","article-title":"Pharmacologic control of aberrant behaviour in the mentally retarded: Toward a more rational approach","volume":"14","author":"Baumeister","year":"1990","journal-title":"Neuroscience & Biobehavioural Reviews"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/070674371105600205","article-title":"Psychiatric conditions and behavioural problems in adolescents with intellectual disabilities: Correlates with Autism?","volume":"56","author":"Bradley","year":"2011","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.ridd.2013.08.015_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/bin.2360050407","article-title":"Case study: Use of propanolol to reduce aggressive behaviour in a woman who is mentally retarded","volume":"5","author":"Calamari","year":"1990","journal-title":"Behavioural Interventions"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0025","first-page":"398","article-title":"Effects of long-acting propanolol on agonistic and stereotyped behaviours in a man with pervasive developmental disorder and fragile X syndrome: A double-blind, placebo-controlled study","volume":"11","author":"Cohen","year":"1991","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.1994.4.101","article-title":"Nadolol for self-injury, overactivity, inattention and aggression in a child with pervasive developmental disorder","volume":"4","author":"Connor","year":"1994","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0035","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00004583-199706000-00021","article-title":"A pilot study of nadolol for overt aggression in developmentally delayed individuals","volume":"36","author":"Connor","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1016\/j.ridd.2013.08.015_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jmg.38.9.586","article-title":"Beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith\u2013Magenis syndrome","volume":"38","author":"De Leersnyder","year":"2001","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.ridd.2013.08.015_bib0045","series-title":"Intellectual disability psychiatry: A practical handbook","first-page":"203","article-title":"Pharmacological interventions","author":"Deb","year":"2009"},{"key":"10.1016\/j.ridd.2013.08.015_bib0050","series-title":"Handbook of psychopathology in intellectual disability: research, practice, and policy, autism and child psychopathology series","article-title":"Psychopharmacology","author":"Deb","year":"2013"},{"key":"10.1016\/j.ridd.2013.08.015_bib0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2788.2001.00373.x","article-title":"Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorder among a community based population aged 16 to 64 years","volume":"45","author":"Deb","year":"2001","journal-title":"Journal of Intellectual Disability Research"},{"issue":"10","key":"10.1016\/j.ridd.2013.08.015_bib0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2788.2007.00950.x","article-title":"The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities","volume":"51","author":"Deb","year":"2007","journal-title":"Journal of Intellectual Disability Research"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2788.2007.00965.x","article-title":"The effectiveness of mood stabilisers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: A systematic review","volume":"52","author":"Deb","year":"2008","journal-title":"Journal of Intellectual Disability Research"},{"issue":"3","key":"10.1016\/j.ridd.2013.08.015_bib0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.2051-5545.2009.tb00248.x","article-title":"International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities","volume":"8","author":"Deb","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ridd.2013.08.015_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"Journal of Epidemiology & Community Health"},{"key":"10.1016\/j.ridd.2013.08.015_bib0080","series-title":"Attention deficit hyperactivity disorder: A clinical workbook","first-page":"49","article-title":"Child attention problem rating scale","author":"Edelbrock","year":"1991"},{"key":"10.1016\/j.ridd.2013.08.015_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00919127","article-title":"Normative data on revised Connors parent and teacher rating scales","volume":"6","author":"Goyette","year":"1978","journal-title":"Journal of Abnormal Child Psychology"},{"key":"10.1016\/j.ridd.2013.08.015_bib0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004714-198410000-00009","article-title":"Propanolol in the treatment of assaultive patients with organic brain disease","volume":"4","author":"Greendyke","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.08.015_bib0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005053-198605000-00005","article-title":"Propanolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study","volume":"174","author":"Greendyke","year":"1986","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.ridd.2013.08.015_bib0100","series-title":"ECDEU assessment manual for psychopharmacology, revised","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"issue":"3 Suppl.","key":"10.1016\/j.ridd.2013.08.015_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Methods work group, third US preventive services task force (2001) current methods of the US preventive services task force: A review of process","author":"Harris","year":"2001","journal-title":"American Journal of Preventive Medicine"},{"issue":"5","key":"10.1016\/j.ridd.2013.08.015_bib0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/10673229509017146","article-title":"Beta blockers and the treatment of aggression","volume":"2","author":"Haspel","year":"1995","journal-title":"Harvard Review of Psychiatry"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1179\/096979510799102934","article-title":"A study on the use of propanolol in managing behavioural problems in people with intellectual disability","volume":"56","author":"Hiremath","year":"2010","journal-title":"The British Journal of Developmental Disabilities"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0120","first-page":"1585","article-title":"Metorprolol for aggressive behaviour in persons with mental retardation","volume":"42","author":"Kastner","year":"1990","journal-title":"American Family Physician"},{"key":"10.1016\/j.ridd.2013.08.015_bib0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0924933800002194","article-title":"Pharmacological treatment of extreme self-injurious behaviour in autism","volume":"7","author":"Knabe","year":"1992","journal-title":"European Psychiatry"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0033-3182(87)72521-3","article-title":"Use of propanolol to decrease aggressive outbursts in younger patients","volume":"28","author":"Kuperman","year":"1987","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0135","first-page":"213","article-title":"Beta adrenoceptor antagonists in neuropsychiatry: An update","volume":"49","author":"Lader","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00004583-199402000-00016","article-title":"Treatment with propanolol of severe self-injurious behaviour in a blind, deaf, retarded adolescent","volume":"33","author":"Lang","year":"1994","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.ridd.2013.08.015_bib0145","first-page":"372","article-title":"Lithium and propanolol in aggression and self-injurious behaviour in the mentally retarded","volume":"25","author":"Luchins","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/106002809502900610","article-title":"Interactions between antipsychotic and antihypertensive drugs","volume":"19","author":"Markowitz","year":"1995","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.ridd.2013.08.015_bib0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-199401060-00004","article-title":"Treating somatic symptoms of anxiety","volume":"1","author":"Morgan","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ridd.2013.08.015_bib0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1192\/pb.26.4.127","article-title":"A community survey establishing the prevalence rate of autistic disorder in adults with learning disability","volume":"26","author":"Morgan","year":"2002","journal-title":"Psychiatric Bulletin"},{"issue":"6","key":"10.1016\/j.ridd.2013.08.015_bib0165","first-page":"114","article-title":"The treatment of impulsive aggressive behaviour with nadolol","volume":"2","author":"Polakoff","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.ridd.2013.08.015_bib0170","series-title":"Mental retardation: Developing pharmacotherapies","first-page":"51","article-title":"Beta blockers as primary treatment for aggression and self-injury in the developmentally disabled","author":"Ratey","year":"1991"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004714-198604000-00009","article-title":"Beta blockers in the severely and profoundly mentally retarded","volume":"6","author":"Ratey","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ridd.2013.08.015_bib0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01487073","article-title":"Brief report: Open trial effects of beta-blockers on speech and social behaviours in 8 autistic adults","volume":"17","author":"Ratey","year":"1987","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.ridd.2013.08.015_bib0185","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005053-199111000-00009","article-title":"Combination of treatments for attention deficit hyperactivity disorder in adults","volume":"179","author":"Ratey","year":"1991","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0190","first-page":"41","volume":"53","author":"Ratey","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ridd.2013.08.015_bib0195","first-page":"110","article-title":"Beta-adrenergic blocking medications for aggressive or self-injurious mentally retarded persons","volume":"95","author":"Ruedrich","year":"1990","journal-title":"American Journal of Mental Retardation"},{"key":"10.1016\/j.ridd.2013.08.015_bib0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1098-2779(1999)5:4<290::AID-MRDD6>3.0.CO;2-6","article-title":"Beta-adrenergic blockers in mental retardation and developmental disabilities","volume":"5","author":"Ruedrich","year":"1999","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"key":"10.1016\/j.ridd.2013.08.015_bib0205","series-title":"Cambridge textbook of effective treatments in psychiatry","first-page":"187","article-title":"Management of behavioural and psychological symptoms of dementia and acquired brain injury","author":"Sadavoy","year":"2008"},{"issue":"2","key":"10.1016\/j.ridd.2013.08.015_bib0210","first-page":"s22","article-title":"Overt aggression scale: Overview and guiding principles","volume":"3","author":"Silver","year":"1991","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"10","key":"10.1016\/j.ridd.2013.08.015_bib0215","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1176\/ajp.143.10.1290","article-title":"Elevation of thioridazine plasma levels by propanolol","volume":"143","author":"Silver","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.ridd.2013.08.015_bib0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1352\/06-034.1","article-title":"The use of medication for the management of behaviour problems in adults with intellectual disabilities: A clinicians\u2019 consensus survey","volume":"113","author":"Unwin","year":"2008","journal-title":"American Journal on Mental Retardation"},{"key":"10.1016\/j.ridd.2013.08.015_bib0225","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ridd.2011.07.031","article-title":"Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review","volume":"32","author":"Unwin","year":"2011","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2013.08.015_bib0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-7138(09)60911-0","article-title":"The effect of propanolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction","volume":"21","author":"Williams","year":"1982","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422213003570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422213003570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T23:13:28Z","timestamp":1716074008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422213003570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0891422213003570"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2013.08.015","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Developmental Disabilities","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ridd.2013.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}